Celltrion proves equivalent effect on Remsima, Remicade and Humira

At the 2018 European Crohn’s and Colitis Organisastion(ECCO) held in Vienna, Austria, large clinical study results on Crohn’s disease patients were revealed.

In these studies, the remission rate of each patient group with Remsima, Remicade and Humira was 39.0%, 39.7% and 32.7% respectively, showing similar efficacies.

Professor Nicholas Kennedy, a gastroenterologist at Royal Deven and Exeter ...